SAN FRANCISCO and SUZHOU, China, Feb. 8, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and...
Hence then, the article about innovent announces strategic collaboration with lilly to develop new medicines globally in oncology and immunology was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Innovent Announces Strategic Collaboration with Lilly to Develop New Medicines Globally in Oncology and Immunology )
Also on site :
- Brownfields sind der wahre Test für die Automatisierung: So skalierte ForwardX 484 AMRs in einem laufenden Automobilwerk eines Erstausrüsters ohne Produktionsausfälle
- Limoncello: Bringing the flavors and spirit of Italy to La Mesa
- Xiao-I Corporation Provides Update on First-Instance Rulings in Patent Litigation Against Apple; Company Intends to Appeal to the Supreme People's Court